Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $35.30M in the twelve months ending March 31, 2024, with 35.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.97M with 50.19% year-over-year growth. In the year 2023, Eton Pharmaceuticals had annual revenue of $32.64M with 42.60% growth.

• Revenue (ttm): $35.30M
• Revenue Growth: +35.69%
• P/S Ratio: 2.58
• Revenue / Employee: $1,176,800
• Employees: 30
• Market Cap: 91.20M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	32.64M	9.75M	42.60%
Dec 31, 2022	22.89M	-441.00K	-1.89%
Dec 31, 2021	23.33M	23.29M	59,725.64%
Dec 31, 2020	39.00K	-920.00K	-95.93%
Dec 31, 2019	959.00K	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.